Aignostics Launches PathoSearch for AI-Driven Pathology Case
Berlin, Germany and New York, NY, September 12, 2026 Aignostics has launched PathoSearch, a new AI-powered visual search engine...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Berlin, Germany and New York, NY, September 12, 2026 Aignostics has launched PathoSearch, a new AI-powered visual search engine...
Santa Clara, California — September 4, 2026 Agilent Technologies Inc. announced the U.S. launch of the Agilent S540MD Slide...
Boston and Tel Aviv, Israel, July 23, 2026 Ibex Medical Analytics announced it has received CE-IVDR certification for Ibex...
SHANGHAI, NANJING, China, and PLEASANTON, Calif., June 18, 2026 IASO Bio has achieved a major international regulatory milestone with...
INDIANAPOLIS, Ind., June 18, 2026 Elanco Animal Health Incorporated has announced plans to establish Elanco Ventures, a dedicated corporate...
SINGAPORE and SEOUL, South Korea, June 17, 2026 D&D Pharmatech and HistoIndex have announced encouraging new findings from an...
BOULDER, Colo., June 16, 2026 Edgewise Therapeutics has announced positive top-line results from the 12-week Phase 2 CIRRUS-HCM trial...
FRIENDSWOOD, Texas, June 16, 2026 Castle Biosciences has announced that its TissueCypher® Barrett’s Esophagus Test has surpassed 100,000 clinical...
SALT LAKE CITY, May 26, 2026 Myriad Genetics announced the launch of Prolaris® + AI, the first prostate cancer...
BASEL, Switzerland – May 7, 2026 Roche announced it has entered into a definitive merger agreement to acquire PathAI,...
